RESEARCH TRIANGLE PARK – Greensboro-based Kepley BioSystems has joined the growing number of North Carolina life sciences companies refocusing their wits resources to combat the spread of COVID-19.
The company announced this week that it filed an accelerated patent for its personal protection air sterilization technology. The pro se patent has been submitted to the U.S. Patent and Trademark Office under the COVID-19 Prioritized Examination Pilot Program, which is designed to accelerate development of solutions targeting the global pandemic.
The new technology developed by Kepley scientists eliminates viral, bacterial and fungal pathogens from the air and can be used in several ways. For individuals, the company envisions a full-face mask connected to a series of multifaceted and antipathogenic pathways that sterilize inhaled and exhaled air. The company anticipates a growing need for the technology among those on the front lines of the pandemic.
“Front line workers need protection from airborne microbes, especially in this dangerous period that demands innovation,” said Terry Brady, Kepley’s chief inventor.
The technology can also be adapted for use in acute medical settings, manufacturing, shipping and food preparation and packaging facilities, as well as in shared, enclosed spaces such as aircraft, operating rooms, auditoriums and cars.
As the patent pro se makes its way through the process, Kepley is seeking partners to join it in the development, manufacturing and marketing of the technology.
“We’re committed to assembling a diverse team of executives, scientists and engineers through collaboration with government and independent enterprise to commercialize this technology,” said President Anthony Dellinger.
The development of the new technology fits into the company’s mission to develop disruptive innovations to achieve global solutions. Currently, it is also developing OrganoBait. The synthetic and sustainable material mimics the odor of decaying fish that attracts crustaceans, making it an alternative bait for attracting lobsters and crabs.
Founded in 2013, Kepley BioSystems’ headquarters are at the Gateway University Research Park facility adjacent to the Joint School of Nanoscience and Nanoengineering (JSNN) research and education facility. Kepley’s proximity to the campus provides access to resources for product development, analytical services, materials testing, analysis and evaluation. JSNN is a collaboration between North Carolina Agricultural & Technical University and the University of North Carolina Greensboro.
(C) N.C. Biotech Center
Original Article Source: WRAL TechWire